Literature DB >> 9242683

Regulation of major histocompatibility complex class I gene expression in thyroid cells. Role of the cAMP response element-like sequence.

M Saji1, M Shong, G Napolitano, L A Palmer, S I Taniguchi, M Ohmori, M Ohta, K Suzuki, S L Kirshner, C Giuliani, D S Singer, L D Kohn.   

Abstract

The major histocompatibility complex (MHC) class I gene cAMP response element (CRE)-like site, -107 to -100 base pairs, is a critical component of a previously unrecognized silencer, -127 to -90 bp, important for thyrotropin (TSH)/cAMP-mediated repression in thyrocytes. TSH/cAMP induced-silencer activity is associated with the formation of novel complexes with the 38-base pair silencer, whose appearance requires the CRE and involves ubiquitous and thyroid-specific proteins as follows: the CRE-binding protein, a Y-box protein termed thyrotropin receptor (TSHR) suppressor element protein-1 (TSEP-1); thyroid transcription factor-1 (TTF-1); and Pax-8. TTF-1 is an enhancer of class I promoter activity; Pax-8 and TSEP-1 are suppressors. TSH/cAMP decreases TTF-1 complex formation with the silencer, thereby decreasing maximal class I expression; TSH/cAMP enhance TSEP-1 and Pax-8 complex formation in association with their repressive actions. Oligonucleotides that bind TSEP-1, not Pax-8, prevent formation of the TSH/cAMP-induced complexes associated with TSH-induced class I suppression, i.e. TSEP-1 appears to be the dominant repressor factor associated with TSH/cAMP-decreased class I activity and formation of the novel complexes. TSEP-1, TTF-1, and/or Pax-8 are involved in TSH/cAMP-induced negative regulation of the TSH receptor gene in thyrocytes, suppression of MHC class II, and up-regulation of thyroglobulin. TSH/cAMP coordinate regulation of common transcription factors may, therefore, be the basis for self-tolerance and the absence of autoimmunity in the face of TSHR-mediated increases in gene products that are important for thyroid growth and function but are able to act as autoantigens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242683     DOI: 10.1074/jbc.272.32.20096

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Cloning and functional analyses of the mouse tapasin promoter.

Authors:  Felix Herrmann; John Trowsdale; Christoph Huber; Barbara Seliger
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

3.  Patterned variation in murine MHC promoters.

Authors:  N Avrion Mitchison; Jurgen Roes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

4.  Autoregulation of thyroid-specific gene transcription by thyroglobulin.

Authors:  K Suzuki; S Lavaroni; A Mori; M Ohta; J Saito; M Pietrarelli; D S Singer; S Kimura; R Katoh; A Kawaoi; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  Thyroid transcription factor 1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells.

Authors:  K Suzuki; S Lavaroni; A Mori; F Okajima; S Kimura; R Katoh; A Kawaoi; L D Kohn
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

6.  Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma.

Authors:  Suriya Narayanan Murugesan; Birendra Singh Yadav; Pramod Kumar Maurya; Amit Chaudhary; Swati Singh; Ashutosh Mani
Journal:  J Genomics       Date:  2018-06-26

7.  Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" Region.

Authors:  Cesidio Giuliani; Sara Verrocchio; Fabio Verginelli; Ines Bucci; Antonino Grassadonia; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-06       Impact factor: 5.555

Review 8.  The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer.

Authors:  Cesidio Giuliani; Ines Bucci; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-21       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.